RDA Scientific Consultants GmbH Sophienstraße 5 D - 80333 München Fon: +49 (0) 89 - 552 797 30 Fax: +49 (0) 89 - 552 797 329 Mail: contact@rda-science.com
The entry into force of the AM-NutzenV on 1 January 2011 brings with it regulations regarding the so called "early" benefit-assessment of medicinal products.
